岭南现代临床外科
嶺南現代臨床外科
령남현대림상외과
LINGNAN MODERN CLINICS IN SURGERY
2014年
3期
274-277
,共4页
郑强%张大伟%卢海武%温子龙%曹良启%薛平
鄭彊%張大偉%盧海武%溫子龍%曹良啟%薛平
정강%장대위%로해무%온자룡%조량계%설평
肝癌%腹腔镜%肝左叶部分切除%生存分析
肝癌%腹腔鏡%肝左葉部分切除%生存分析
간암%복강경%간좌협부분절제%생존분석
Hepatocellular carcinoma%Laparoscopy%Partial left liver resection%Survival analysis
目的:探讨腹腔镜肝左叶部分切除治疗肝癌的近期及远期临床疗效。方法回顾性分析2008年5月~2012年6月我科51例腹腔镜下肝左叶部分切除术(腹腔镜组)与50例开腹肝左叶部分切除术(开腹组)的临床资料,比较两组患者手术时间、术中出血量、住院时间、并发症、住院费用和生存率、复发率。结果腹腔镜组手术时间长于开腹组(128.6±29.7 min vs 106.3±26.5 min, P<0.05),术中出血量多于开腹组(180.5±53.6 mL vs 130.2±44.5 mL, P<0.05),住院时间短于开腹组(6.8±1.4 d vs 11.4±3.0 d,P<0.05),住院费用少于开腹组(3.1±0.5万元 vs 3.3±0.6万元, P<0.05),两组术后并发症发生率(3.9% vs 6.0%)无差异。腹腔镜组中位生存时间为40个月,1、2、3年生存率分别为90.2%、80.4%、68.6%;开腹组中位生存时间为41个月,1、2、3年生存率分别为90.0%、82.0%、66.0%。腹腔镜组中位无瘤生存时间为29个月,l、2、3年复发率分别为19.6%、45.1%、54.9%;开腹组中位无瘤生存时间为31个月,1、2、3年复发率分别为22.0%、42.0%、50.0%。结论腹腔镜肝左叶部分切除安全可行,不影响肝癌患者的预后,与开腹手术相比,具有微创,术后恢复快,住院时间短,费用低的优势。
目的:探討腹腔鏡肝左葉部分切除治療肝癌的近期及遠期臨床療效。方法迴顧性分析2008年5月~2012年6月我科51例腹腔鏡下肝左葉部分切除術(腹腔鏡組)與50例開腹肝左葉部分切除術(開腹組)的臨床資料,比較兩組患者手術時間、術中齣血量、住院時間、併髮癥、住院費用和生存率、複髮率。結果腹腔鏡組手術時間長于開腹組(128.6±29.7 min vs 106.3±26.5 min, P<0.05),術中齣血量多于開腹組(180.5±53.6 mL vs 130.2±44.5 mL, P<0.05),住院時間短于開腹組(6.8±1.4 d vs 11.4±3.0 d,P<0.05),住院費用少于開腹組(3.1±0.5萬元 vs 3.3±0.6萬元, P<0.05),兩組術後併髮癥髮生率(3.9% vs 6.0%)無差異。腹腔鏡組中位生存時間為40箇月,1、2、3年生存率分彆為90.2%、80.4%、68.6%;開腹組中位生存時間為41箇月,1、2、3年生存率分彆為90.0%、82.0%、66.0%。腹腔鏡組中位無瘤生存時間為29箇月,l、2、3年複髮率分彆為19.6%、45.1%、54.9%;開腹組中位無瘤生存時間為31箇月,1、2、3年複髮率分彆為22.0%、42.0%、50.0%。結論腹腔鏡肝左葉部分切除安全可行,不影響肝癌患者的預後,與開腹手術相比,具有微創,術後恢複快,住院時間短,費用低的優勢。
목적:탐토복강경간좌협부분절제치료간암적근기급원기림상료효。방법회고성분석2008년5월~2012년6월아과51례복강경하간좌협부분절제술(복강경조)여50례개복간좌협부분절제술(개복조)적림상자료,비교량조환자수술시간、술중출혈량、주원시간、병발증、주원비용화생존솔、복발솔。결과복강경조수술시간장우개복조(128.6±29.7 min vs 106.3±26.5 min, P<0.05),술중출혈량다우개복조(180.5±53.6 mL vs 130.2±44.5 mL, P<0.05),주원시간단우개복조(6.8±1.4 d vs 11.4±3.0 d,P<0.05),주원비용소우개복조(3.1±0.5만원 vs 3.3±0.6만원, P<0.05),량조술후병발증발생솔(3.9% vs 6.0%)무차이。복강경조중위생존시간위40개월,1、2、3년생존솔분별위90.2%、80.4%、68.6%;개복조중위생존시간위41개월,1、2、3년생존솔분별위90.0%、82.0%、66.0%。복강경조중위무류생존시간위29개월,l、2、3년복발솔분별위19.6%、45.1%、54.9%;개복조중위무류생존시간위31개월,1、2、3년복발솔분별위22.0%、42.0%、50.0%。결론복강경간좌협부분절제안전가행,불영향간암환자적예후,여개복수술상비,구유미창,술후회복쾌,주원시간단,비용저적우세。
Objective To evaluate the short- and long-term efficacy of laparoscopic partial left liver resection for treatment of hepatocellular carcinoma. Methods The clinical data of 51 patients who received laparoscopic partial left liver resection(laparoscopic group) were retrospectively compared with 50 patients who underwent open partial left liver resection (open group) from May 2008 to June 2012. The duration of operation, intraoperative blood loss, hospital stay, postoperative complications, hospital cost and the rate of survival and recurrence were compared respectively. Results The duration of opera-tion was longer in laparoscopic group than that in open group(128.6±29.7 min vs 106.3±26.5 min, P<0.05), the blood loss during operation was more than that in open group (180.5±53.6 ml vs 130.2±44.5 ml, P<0.05)..Average hospital stay in laparoscopic group was shorter than that in open group (6.8±1.4 d vs 11.4±3.0, P<0.05)..Total hospital cost in laparoscopic group was lower than that in open group(P<0.05). The rate of postoperative complications between the two groups was not statistically significant. .The median overall survival time was 40 months in laparoscopic group and 41 in open group. The 1-, 2-and 3-year survival rate was 90.2%, 80.4%, 68.6%, respectively in laparoscopic group and 90.0%,. 82.0%,.66.0%in open group. The median disease-free survival time was 29 months in laparoscopic group and 31 in open group. The 1-,2- and 3-year recurrence rate was 19.6%,45.1%, and 54.9%, respectively in laparoscopic group and 22.0%,42.0%and 50.0%in open group..Conclusion Laparoscopic partial left liver resection is safe and feasible,.and has similar effect on prognosis of patients with hepatocellular carcinoma. When Compared with open surgery. and laparoscopic surgery have some advantages, including minimally invasive,.faster recovery,.shorter hospital stay and lower cost..